Jan 29, 2018 12:31 pm UTC| Business
CRANBURY, N.J., Jan. 29, 2018 -- Amicus Therapeutics (Nasdaq:FOLD) announced that the Common Drug Review (CDR) has posted the Canadian Drug Expert Committee (CDEC)’s positive recommendation of Galafold™ (migalastat) for...
Macatawa Bank Corporation Increases Quarterly Dividend
Jan 29, 2018 12:30 pm UTC| Business
HOLLAND, Mich., Jan. 29, 2018 -- Macatawa Bank Corporation (Nasdaq:MCBC) (the "Company" or "Macatawa") today announced that its Board of Directors has declared a quarterly cash dividend of $0.06 per share on...
Holiday Island Holdings Announces the Island Bistro Grand Opening This Week
Jan 29, 2018 12:20 pm UTC| Business
HOLIDAY ISLAND, Ark., Jan. 29, 2018 -- Holiday Island Holdings, Inc. (OTCPink:HIHI) - a development stage company operating in the land development sector of the real estate market – released the news today that the...
Norsk Hydro: Invitation - Hydro's fourth quarter results 2017
Jan 29, 2018 12:19 pm UTC| Business
Hydro's fourth quarter results 2017 will be released at 07:00 CET (01:00 AM EST, 06:00 UK time), on Friday February 16, 2018. The quarterly report and presentation slides will be available on www.hydro.com at the same...
Jan 29, 2018 12:10 pm UTC| Business
LONDON, Jan. 29, 2018 -- Let’s face it, undergraduate degrees are commonplace these days. They provide a great foundation, but are by no means the differentiating factor they used to be. Fortunately, those seeking to...
Jan 29, 2018 12:10 pm UTC| Business
BOTHELL, Wash., Jan. 29, 2018 -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, announced today an...
Faron Pharmaceuticals Oy: FDA grants Fast Track Designation to Faron for Traumakine®
Jan 29, 2018 12:01 pm UTC| Business
Faron Pharmaceuticals Ltd("Faron" or the "Company") FDA grants Fast Track Designation to Faron for Traumakine® Faron's wholly-owned product for Acute Respiratory Distress Syndrome on track for Phase III data in...